Money · Lobbying reports · 119th Congress
S. 1954
29 saved lobbying reports name S. 1954.
29 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:39 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| BCBSM, INC. | BCBSM INC | $30,000.00reported as expenses | July to September 2026 | Open the report | |
| THE NICKLES GROUP, LLC | AMGEN | $60,000.00reported as income | July to September 2026 | Open the report | |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | $250,000.00reported as expenses | July to September 2026 | Open the report | |
| BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | $10,000.00reported as expenses | July to September 2026 | Open the report | |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | July to September 2026 | Open the report | |
| THE PERMANENTE FEDERATION, LLC | THE PERMANENTE FEDERATION, LLC | $110,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,040,000.00reported as expenses | July to September 2026 | Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $1,530,000.00reported as expenses | July to September 2026 | Open the report | |
| COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | $340,000.00reported as income | July to September 2026 | Open the report | |
| AMGEN, INC. | AMGEN INC | $3,150,000.00reported as expenses | July to September 2026 | Open the report | |
| AVENUE SOLUTIONS | AMGEN, INC. | $50,000.00reported as income | July to September 2026 | Open the report | |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $2,220,000.00reported as expenses | July to September 2026 | Open the report | |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | $100,000.00reported as expenses | July to September 2026 | Open the report | |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $1,240,000.00reported as expenses | July to September 2026 | Open the report | |
| THORN RUN PARTNERS | THE BIOSIMILARS FORUM | $100,000.00reported as income | July to September 2026 | Open the report | |
| GUIDEWELL MUTUAL HOLDING CORPORATION | GUIDEWELL MUTUAL HOLDING CORPORATION | The report gives no amount | July to September 2026 | Open the report | |
| AMERICAN COLLEGE OF RHEUMATOLOGY | AMERICAN COLLEGE OF RHEUMATOLOGY | $50,000.00reported as expenses | July to September 2026 | Open the report | |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $120,000.00reported as expenses | July to September 2026 | Open the report | |
| FRESENIUS KABI USA LLC | FRESENIUS KABI USA LLC | $630,000.00reported as expenses | July to September 2026 | Open the report | |
| VIZIENT, INC. | VIZIENT INC | $300,000.00reported as expenses | July to September 2026 | Open the report | |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TAKEDA PHARMACEUTICALS AMERICA INC | $1,450,000.00reported as expenses | July to September 2026 | Open the report | |
| FIERCE GOVERNMENT RELATIONS | ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) | $60,000.00reported as income | July to September 2026 | Open the report | |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000.00reported as income | July to September 2026 | Open the report | |
| MEHLMAN CONSULTING, INC. | ASSOCIATION OF ACCESSIBLE MEDICINES | $60,000.00reported as income | July to September 2026 | Open the report | |
| TIBER CREEK GROUP | AMGEN INC | $60,000.00reported as income | July to September 2026 | Open the report | |
| PRIME THERAPEUTICS | PRIME THERAPEUTICS | $140,000.00reported as expenses | July to September 2026 | Open the report | |
| KAISER FOUNDATION HEALTH PLAN INC. | KAISER FOUNDATION HEALTH PLAN INC | $500,000.00reported as expenses | July to September 2026 | Open the report | |
| CAMBIA HEALTH SOLUTIONS | CAMBIA HEALTH SOLUTIONS | $670,000.00reported as expenses | July to September 2026 | Open the report | |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $80,000.00reported as expenses | July to September 2026 | Open the report |